Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03219229 · ClinicalTrials.gov registry record
Metabolic Effects of Differential Organ Growth Rates
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 49
- Enrollment target
NCT03219229: Completed study, sponsored by Columbia University.
NCT03219229 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03219229 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Young children have a high resting energy expenditure (REE) relative to their body weight and metabolically active compartment, fat-free mass (FFM). Both body weight and FFM are, however, metabolically heterogeneous and include organs and tissues varying widely in specific metabolic rate (i.e., organ REE/kg/d). One prevailing hypothesis is that most, if not all, of the higher REE observed in young animals and children compared to adults can be accounted for by a larger proportion of high metabolic rate components such as brain, liver, and heart..
Primary Outcome
REE is measured by indirect calorimetry over a 30 minute period and extrapolated to a 24 hour period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2004-02-14 |
| Est. Completion | 2007-02-20 |
What the finished NCT03219229 record still lists
NCT03219229 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03219229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03219229 about?
NCT03219229 is a clinical study titled "Metabolic Effects of Differential Organ Growth Rates". Young children have a high resting energy expenditure (REE) relative to their body weight and metabolically active compartment, fat-free mass (FFM). Both body weight and FFM are, however, metabolically heterogeneous and include organs and tissues varying widely in specific metabolic rate (i.e., orga...
What is the current status of trial NCT03219229?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2004-02-14. Estimated completion is 2007-02-20.
Who is sponsoring clinical trial NCT03219229?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI